 encourag progress
messag came away result encourag progress
compani made seven month sinc bryan hanson took ceo
much work remain done turnaround appear larg track
expect overt sign improv move
rais price target reiter buy rate
step right direct good news balanc view
friday call posit updat show zimmer make meaning progress
turnaround effort ceo bryan hanson quick note much work remain done
qualiti remedi suppli front yet also indic suppli
situat improv consider sinc earli part year constraint
unlik prevent compani achiev full year outlook worth note
manag felt confid enough front rais organ growth target
meanwhil although zimmer continu lag behind broader recon market
margin under-perform narrow consider constant currenc basi
adjust sell day compani world-wide recon growth fell short
market gap shrunk past quarter trend
believ could continu next quarter combin easi comp
ramp suppli new product launch help zimmer build momentum
unfortun non-recon portion compani portfolio mix bag
 dental weaken sequenti offset improv spine
perform manag chalk shortfal linger suppli constraint
time capit order given import segment zimmer long-
term growth trajectori watch close sign rebound back half
year dental said year believ busi
make sens divestitur candid part zimmer long-term
plan see quarter improv perform might improv
compani negoti posit potenti sale lack notic progress
discourag
continu model adjust ep top line
forecast total revenu organ compar prior estim
decreas due entir lower assum currenc benefit
vs number final bottom one quarter solid
execut belt see zimmer much easier stori today
six month ago time valu hard come large-cap med-tech
continu view attract turnaround play rais price target
reiter buy rate
sector medic suppli devic
page analyst certif import disclosur
zimmer merger biomet made player hip knee wide
margin share global recon sale deal provid compani
ep accret scale also left zimmer sale come slow growth
market underperform late under-perform
exacerb past month chronic manufactur issu suppli
constraint leav zimmer unabl servic client base effect remedi
issu taken far longer manag origin anticip believ
compani posit return normal inventori level
drive improv top line growth profit long-term continu see
opportun addit valu creation commit shed non-cor
asset diversifi higher growth adjac think strateg shift
would view posit street result higher multipl stock
today trade signific discount rest large-cap med-tech group
zimmer share current trade ntm ep estim ntm
ebitda well large-cap med-tech averag view
discount broader group justifi given zimmer inferior top line growth trajectori
vs see current valuat gap excess expect share
re-rat upward market discount possibl new manag drive
growth reacceler rais price target previous
base multipl previous revis forward ntm
ep estim signific upsid potenti target current level assign
zimmer share buy rate
downsid risk rate includ failur attract talent new leadership and/or
implement strateg shift drive sustain valu creation increas price and/or
volum pressur ortho implant manufactur bundl payment initi
greater anticip share loss recon due linger suppli constraint
page analyst certif import disclosur
million usd except
good sold
compani report guggenheim secur llc estim
page analyst certif import disclosur
figur annual revenu build pro forma bmet deal jan
million usd
compani report guggenheim secur llc estim
page analyst certif import disclosur
